Deborah Kletzky Schlossman MD

Ophthalmology•Boston, MA

Cataract Related, Glaucoma Related, Retinal Disease

Assistant Professor of Ophthalmology, Harvard Medical School

Join to View Full Profile

1 Joslin PlaceBoston, MA 02215
Phone+1 617-309-2554

Summary

Dr. Deborah Kletzky Schlossman is an Assistant Professor of Ophthalmology at Harvard Medical School in Boston, MA. She is affiliated with multiple hospitals in the area including Beth Israel Deaconess Medical Center, Massachusetts Eye and Ear, and Brigham and Women's Hospital. She received her medical degree from Tufts University School of Medicine and has been in practice 29 years. She specializes in cataract surgery and and diabetic retinal disease.

Education & Training

Joslin Diabetes CenterFellowship, Diabetic Eye Disease, 1992 - 1993
MedStar Health Georgetown UniversityResidency, Ophthalmology, 1989 - 1992
New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1988 - 1989
Tufts University School of MedicineClass of 1988

Certifications & Licensure

MA State Medical License 1992 - 2027
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Alpha Omega Alpha (AOA) Honor Society 1987
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2003 Jul 01
Completed
Phase 2
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) Start of enrollment: 2006 Jun 01
Completed
Phase 2
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema Start of enrollment: 2004 Dec 01
Completed
Phase 2
The Course of Response to Focal Photocoagulation for DME Start of enrollment: 2007 Jan 01
Completed
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
Completed
Phase 3
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
COMPLETED
PHASE2
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Start of enrollment: 2012 Mar 01
Completed
Phase 3
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Start of enrollment: 2012 Aug 01
Completed
Phase 3
Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
Completed
Phase 3
Phase II Combination Steroid and Anti-VEGF for Persistent DME Start of enrollment: 2014 Feb 01
Completed
Phase 2
The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates Start of enrollment: 2015 Aug 01
Completed
Phase 1, Phase 2
Anti-VEGF Treatment for Prevention of PDR/DME Start of enrollment: 2016 Jan 01
Completed
Phase 3
PRP vs Bevacizumab for PDR Treatment Start of enrollment: 2016 Feb 01
Completed
Phase 2, Phase 3
Anti-VEGF vs. Prompt Vitrectomy for VH From PDR Start of enrollment: 2016 Nov 01
Completed
Phase 2, Phase 3
DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME Start of enrollment: 2017 Dec 07
Completed
Phase 3
PROMINENT-Eye Ancillary Study (Protocol AD) Start of enrollment: 2018 Jan 15
Terminated
Phase 3
Effects of Pneumatic Vitreolysis on Vitreomacular Traction Start of enrollment: 2018 Oct 16
Completed
Phase 3
Effects of Pneumatic Vitreolysis on Macular Hole Start of enrollment: 2018 Nov 14
Completed
Not Applicable
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema Start of enrollment: 2019 Apr 10
Completed
Not Applicable
Fenofibrate for Prevention of DR Worsening Start of enrollment: 2021 Mar 05
Recruiting
Phase 3
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy Start of enrollment: 2021 Mar 30
Completed
Phase 4
Evaluation of Tonabersat for DME Start of enrollment: 2023 May 02
ACTIVE_NOT_RECRUITING
PHASE2
Randomized Trial Comparing Immediate Vs. Deferred Surgery for Symptomatic ERM Start of enrollment: 2022 Feb 22
RECRUITING
NA
Join now to see all

Publications & Presentations

PubMed

Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy.
Lloyd Paul Aiello, Barbara Blodi, Xiaoyu Gao, Jennifer K Sun, Rose A Gubitosi-Klug
JAMA Ophthalmology. 2024-09-01
9 citations
Cost-effectiveness of Aflibercept Monotherapy vs Bevacizumab First Followed by Aflibercept If Needed for Diabetic Macular Edema.
David W Hutton, Adam R Glassman, Danni Liu, Jennifer K Sun,
JAMA Ophthalmology. 2023-03-01
38 citations
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over Time.
Dennis M Marcus, Paolo S Silva, Danni Liu, Lloyd Paul Aiello, Andrew Antoszyk
JAMA Ophthalmology. 2022-10-01

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

External Links

Joslin https://eye.hms.harvard.edu/deborahschlossman
Paintingshttps://www.deborahschlossman.com/
Instagramhttps://www.instagram.com/dschlossman